← Back to Search

Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry (VIGILANT Trial)

N/A
Waitlist Available
Research Sponsored by Arbor Pharmaceuticals, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 3 years
Awards & highlights
No Placebo-Only Group

Summary

This is a prospective, observational registry in patients who have been prescribed Gliadel Wafer by the physician as part of usual care.

Eligible Conditions
  • Brain Tumor

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
To evaluate the disease-specific survival rate for patients treated with Gliadel Wafer
To evaluate the overall survival rate for patients treated with Gliadel Wafer
To evaluate the progression-free survival rate for patients treated with Gliadel Wafer
Secondary study objectives
To evaluate change in patient health status over time via a practitioner/proxy reported scale
To evaluate change in patient health status over time via patient reported outcomes (PRO)
To evaluate events of interest (EOI) in patients treated with Gliadel Wafer.
+3 more
Other study objectives
To evaluate health care utilization though length of hospital stays for the primary procedure and any subsequent hospitalizations in patients treated with Gliadel Wafer

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Find a Location

Who is running the clinical trial?

Arbor Pharmaceuticals, Inc.Lead Sponsor
16 Previous Clinical Trials
2,043 Total Patients Enrolled
Evan Scullin, MDStudy ChairArbor Pharmaceuticals, LLC is a subsidiary of Azurity Pharmaceuticals, Inc."
1 Previous Clinical Trials
40 Total Patients Enrolled
~26 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top